CA Stock MarketDetailed Quotes
DTC Defence Therapeutics Inc
- 0.880
- +0.030+3.53%
15min DelayMarket Closed Jul 12 15:19 ET
40.07MMarket Cap-4631P/E (TTM)
0.890High0.850Low124.61KVolume0.850Open0.850Pre Close106.71KTurnover3.04052wk High0.29%Turnover Ratio45.54MShares0.68052wk Low-0.19EPS TTM37.85MFloat Cap8.150Historical HighLossP/E (Static)43.01MShs Float0.680Historical Low-0.2EPS LYR4.71%Amplitude--Dividend TTM-17.60P/B1Lot Size--Div YieldTTM
Defence Therapeutics Inc Key Stats
Quarterly+Annual
YOY
| (Q3)Mar 31, 2024 | (Q2)Dec 31, 2023 | (Q1)Sep 30, 2023 | (Q3)Mar 31, 2023 | (Q2)Dec 31, 2022 | (Q1)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q4)Jun 30, 2022 | (Q3)Mar 31, 2022 | (Q2)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 48.00%-940.92K | 35.76%-1.39M | 7.09%-1.42M | -16.88%-1.81M | -25.96%-2.17M | -1.79%-1.53M | -163.99%-6.04M | 1.98%-1.27M | -196.71%-1.55M | -330.90%-1.72M |
| Net income from continuing operations | 1.15%-1.33M | -318.50%-8.32M | -29.03%-2.2M | 20.74%-1.34M | -2.42%-1.99M | -11.30%-1.7M | -156.85%-7.34M | -29.30%-2.18M | -145.33%-1.69M | -338.90%-1.94M |
| Depreciation and amortization | 7,813.33%22.55K | -45.50%6.95K | --12.79K | --285 | --12.75K | --0 | ---- | ---- | --0 | ---- |
| Remuneration paid in stock | --0 | 2,461.54%5.84M | --0 | --63.18K | -8.31%227.86K | -88.12%4.14K | -38.74%371.27K | -81.06%87.92K | --0 | --248.5K |
| Other non cashItems | -12.50%94.86K | --58.08K | --95.96K | --108.41K | ---- | ---- | ---- | ---- | ---- | ---- |
| Change In working capital | 142.22%269.43K | 316.67%1.02M | 295.55%666.75K | -535.27%-638.08K | -1,497.94%-472.88K | 2,193.16%168.56K | 2,649.52%928.33K | 1,177.16%819.39K | 157.63%146.59K | -330.39%-29.59K |
| -Change in receivables | 183.59%12.41K | 64.26%-12.47K | 917.17%89.07K | -2,943.87%-14.85K | -145.66%-34.88K | 60.21%-10.9K | 161.25%43.87K | 83.42%-5.66K | 102.25%522 | --76.4K |
| -Change in prepaid assets | 56.09%42.82K | 32.00%-21.31K | 653.02%406.69K | -76.76%27.43K | 57.07%-31.35K | 130.78%54.01K | -159.74%-100.5K | 510.44%29.95K | 9,549.00%118.02K | -2,489.82%-73.01K |
| -Change in payables and accrued expense | 132.92%214.2K | 360.27%1.06M | 36.30%170.99K | -2,419.35%-650.67K | -1,132.98%-406.65K | -35.60%125.46K | 1,232.75%984.97K | 2,393.58%795.09K | -65.50%28.05K | -236.67%-32.98K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 48.00%-940.92K | 35.76%-1.39M | 7.09%-1.42M | -16.88%-1.81M | -25.96%-2.17M | -1.79%-1.53M | -163.99%-6.04M | 1.98%-1.27M | -196.71%-1.55M | -330.90%-1.72M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -213.68K | 0 | -6.5K | 0 | -60.77K | 0 | 0 | |||
| Net PPE purchase and sale | ---213.68K | --0 | ---6.5K | --0 | ---60.77K | --0 | ---- | ---- | --0 | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---213.68K | --0 | ---6.5K | --0 | ---60.77K | --0 | ---- | ---- | --0 | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -70.87%1.32M | -82.56%394.52K | -101.27%-14.66K | 1,460.81%4.52M | 3,683.22%2.26M | 106.15%1.15M | -81.31%1.1M | 72.22%188.58K | 242.66%289.89K | -98.82%59.78K |
| Net issuance payments of debt | 554.43%28.38K | ---- | ---- | ---6.25K | ---- | ---- | ---- | ---- | --0 | ---- |
| Net common stock issuance | -69.46%1.45M | 305.89%423.75K | --0 | 1,538.55%4.75M | 74.64%104.4K | 116.07%1.21M | -60.18%1.1M | 72.22%188.58K | 11,978.75%289.89K | -97.03%59.78K |
| Cash dividends paid | ---- | ---- | --0 | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | ---- | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Interest paid (cash flow from financing activities) | ---- | ---- | ---14.66K | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Net other financing activities | ---- | ---- | ---- | ---219.13K | ---197.79K | ---55.59K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -70.87%1.32M | -82.56%394.52K | -101.27%-14.66K | 1,460.81%4.52M | 3,683.22%2.26M | 106.15%1.15M | -81.31%1.1M | 72.22%188.58K | 242.66%289.89K | -98.82%59.78K |
| Net cash flow | ||||||||||
| Beginning cash position | 116.09%351K | 931.90%1.35M | 451.20%2.79M | -94.30%162.43K | -97.10%130.84K | -90.71%506.7K | 192.24%5.45M | -76.07%1.59M | -59.77%2.85M | 88.71%4.51M |
| Current changes in cash | -93.98%163.53K | -3,262.45%-999.11K | -283.87%-1.44M | 315.82%2.72M | 101.90%31.59K | 60.15%-375.86K | -237.89%-4.95M | 8.82%-1.08M | -187.82%-1.26M | -135.46%-1.66M |
| End cash Position | -82.12%514.53K | 116.09%351K | 931.90%1.35M | 81.09%2.88M | -94.30%162.43K | -97.10%130.84K | -90.71%506.7K | -90.71%506.7K | -76.07%1.59M | -59.77%2.85M |
| Free cash from | 36.19%-1.15M | 37.51%-1.39M | 6.66%-1.43M | -16.88%-1.81M | -29.49%-2.23M | -1.79%-1.53M | -163.99%-6.04M | 1.98%-1.27M | -196.71%-1.55M | -330.90%-1.72M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
Heat List
CA
Overall
Symbol
Latest Price
%Chg